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Fibroblast growth factors (FGFs) can be classified as secretory (FGF1-10 and FGF15-23) or intracellular non-secretory forms 
(FGF11-14). Secretory forms of FGF and their receptors are best known for their regulatory roles in cell growth, differentiation 
and morphogenesis in the early stages of neural development. However, the functions of intracellular FGFs remain to be ex-
plored. FGF12 and FGF14 are found to interact with voltage-gated sodium channels, and regulate the channel activity in neu-
rons. FGF13 is expressed in primary sensory neurons, and is colocalized with sodium channels at the nodes of Ranvier along 
the myelinated afferent fibers. FGF13 is also expressed in cerebral cortical neurons during the late developmental stage. A re-
cent study showed that FGF13 is a microtubule-stabilizing protein required for regulating the neuronal development in the 
cerebral cortex. Thus, non-secretory forms of FGF appear to have important roles in the brain, and it would be interesting to 
further investigate the functions of intracellular FGFs in the nervous system and in neural diseases. 
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Fibroblast growth factors (FGFs) belong to a family of sig-
naling proteins that play diverse roles in cell growth, dif-
ferentiation, morphogenesis and developmental processes 
[1–4]. Members of the FGF superfamily can be classified as 
secretory or intracellular non-secretory forms (Figure 1). 
Secretory FGFs (FGF1–10 and FGF15–23) contain an 
N-terminal signal peptide for secretion and function via 
their receptors (FGF receptor 1–4), whereas intracellular 
FGFs (FGF11 family, FGF11–14) lack the signal peptide 
and thus may function intracellularly [5,6]. FGF11, FGF12, 
FGF13 and FGF14 were previously named FGF homolo-
gous factors (FHF) 3, FHF1, FHF2 and FHF4, respectively. 
These four FGF members are prominently expressed in the 
nervous system. They form a distinct family and show 
30%–50% amino acid sequence identity with other FGFs 
[7]. Within these four FGFs, different members share 
60%–70% amino acid sequence identity. 
Each intracellular FGF gene has two or more sites for in-
itiating transcription, which leads to the generation of mul-
tiple messenger RNAs with distinct first exons spliced to 
common exons II–V. These are then translated to produce 
proteins with different amino-terminal sequences [5] (Fig-
ure 1). Of the four intracellular forms of FGF, “A” isoforms 
contain long N-terminal extensions that show extensive 
sequence homology to one another. “A” isoforms contain a 
nuclear localization signal (NLS) in the N-treminal region, 
whereas “B” isoforms do not have NLS. Thus, “A” 
isoforms transfected into cells often show nuclear localiza-
tion, while “B” isoforms display cytoplasmic localization.  
Accumulated evidence shows that secretory FGFs and  
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Figure 1  Family members of FGF ligands and receptors. Until now, 23 members (FGF1–FGF23) have been identified in humans and mice. The mamma-
lian FGFs can be divided into the 7 families. Among them, FGF4, FGF5, FGF8, FGF9 and FGF10 families are defined as canonical FGFs (cFGFs), the 
FGF15/19 family is defined as hormone-like FGFs (hFGFs) and the FGF11 family is known as intracellular FGFs (iFGFs). All FGFs contain the homolo-
gous region of ~120 amino acids which is known as the core domain. Most FGFs have N-terminal signal peptides (SP) and can be secreted constitutively. 
However, the FGF9 family (FGF9, 16 and 20) have uncleavable signal peptides but can still be efficiently secreted. FGF1 and FGF2 lack signal peptides and 
can be released by exocytosis or from damaged cells which are non-canonical release pathways, independent of the endoplasmic reticulum-Golgi pathway. 
In particular, the FGF11 family (FGF11, 12, 13 and 14) which lacks signal peptides remains intracellular and functions within cells in a receptor-independent 
manner. FGF11 family genes have two or more isoforms produced by different transcription initiations. The A isoforms of FGF11 family members contain 
N-terminal nuclear localization signals (NLSs). FGF receptors are composed of 4 members (FGFR1–4). The receptors can be further divided to IIIb and IIIc  
isoforms. The binding specificity of FGF ligands and receptors are shown in the figure. 
their receptors play essential roles in the early stages of 
neural development [4]. Some secretory FGFs are also in-
volved in affective disorders and modulate emotionality in 
animal models [8]. Conversely, knowledge about the func-
tions and related mechanisms of intracellular FGFs in the 
nervous system is still limited when compared with what is 
known about secretory FGFs and their receptors. It is 
known that intracellular FGFs can interact with volt-
age-gated Na+ (Nav) channels, and are required for normal 
motor function [5]. Recently, we also found that FGF13B is 
required for the development of the cerebral cortex [9].  
Although the expression and functions of FGFs have 
been summarized and discussed recently [4,5], we feel that 
it is necessary to further summarize and discuss the research 
progress of intracellular FGFs in particular. Therefore, the 
present review will focus on recent studies of the expression 
and functional roles of intracellular FGFs in the nervous 
system (Table 1). The potential roles of intracellular FGFs 
in neural diseases will be also discussed.  
1  Expression of intracellular FGFs in the 
nervous system 
Members of the FGF11 family are expressed in cerebral 
cortical neurons during development [5,7,9,21]. FGF13 is 
also widely distributed in the developing brain with an ex-
pression level ~5-fold higher than FGF11, FGF12 and 
FGF14 [7]. Two alternatively spliced isoforms of FGF13 
have been identified: FGF13A, which contains a NLS, and 
cytoplasmic FGF13B which does not contain a NLS [7,22]. 
FGF13B expression in the cerebral cortex of mice and rats 
gradually increases from embryonic day 14 (E14) until 
postnatal day 7 (P7), after which its expression level begins 
to decrease [9]. In the developing brain of mice, FGF13 is 
present in the subplate (SP), ganglionic eminences (GE) and 
proliferative zones of the cortical wall [the ventricular zone 
(VZ) and the subventricular zone (SVZ)] at E14. It is pre-
sent in the cortical plate (CP) of the cerebral cortex, hippo-
campus and striatum from E17 to P14. FGF13 expression is 
largely absent in the adult mouse brain, except for low lev-
els in the hippocampus.  
In contrast to brain, the dorsal root ganglia (DRG) show 
expression of FGF13 and FGF14 in adult animals [23,24]. 
FGF13 is expressed in 60% of DRG neurons under normal 
circumstances [23]. It has been shown that the gene expres-
sion profiles of DRG and the dorsal spinal cord are modi-
fied by peripheral nerve injury, leading to gene-regulation 
of many molecules, such as neurotransmitter receptors, ion 
channels and the Na+,K+-ATPase activator [25–30]. Indeed, 
after sciatic nerve transection, the expression of FGF2 and 
FGF7 increased in the DRG, whereas FGF13 expression 
decreased [23,24]. Seven days after nerve injury, FGF13-     
containing neurons decreased to 18%, and partially recov-
ered to 40% at 28 days after injury. Despite these observed 
changes in FGF expression, their functional role in DRG 
neurons under normal circumstances and after nerve injury 
remain to be explored.  
It is interesting to note that the expression patterns of 
non-secretory FGFs in the central nervous system are dif-
ferent from that in the peripheral nervous system during 
development and adulthood. A particular example is the  
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Table 1  Function of FGF11 family members in the nervous system 
 Knockout Knockdown Overexpression Mutation 
FGF12 Fgf12
//Fgf14/ mice show se-
vere ataxia behavior [10]. 
   
FGF13 
FGF13-deficient mice show neu-
ronal migration defects in both 
neocortex and hippocampus and 
weakened learning and memory 
[9]. 
Knockdown of FGF13 impairs 
neuronal polarization and in-
creases the branching of axons 
and leading processes [9]. 
 
In utero electroporation with 
FGF13 shRNA leads to neu-
ronal migration defect in the 
somatosensory cortex [9]. 
Overexpression of FGF13B in 
ND7/23 cells increases the peak 
current amplitude and causes 
depolarizing shift of voltage- 




duces stabilization of micro-
tubule bundles in cultured 
cortical neurons [9]. 
Interruption of Fgf13 by a duplica-
tion breakpoint in human is associat-
ed with XLMR [12].  
FGF14 
Fgf12//Fgf14/ mice show se-
vere ataxia behavior [10]. 
 
FGF14-deficient mice show re-
duced responses to dopamine 
receptor agonists, and display the 
paroxysmal hyperkinetic move-
ment disorder [13]. 
 
Fgf14/ mice show abnormalities 
in synaptic plasticity in hippo-
campus. [14]. 
 
Fgf14/ mice exhibit impaired 
spatial learning and defective theta 
burst-induced LTP [15]. 
 
Fgf14/ mice show impaired 
spontaneous and repetitive firing 
in Purkinje neurons [16]. 
 
Overexpression of FGF14-1a/b 
alters Nav channel currents, 
and shifts the voltage depend-
ence of Nav channel activation 
and inactivation [17]. 
FGF14F145S mutation is associated 
with autosomal dominant cerebral 
ataxia [18]. 
 
Frame-shift mutation in the exon 4 of 
FGF14 gene and DNA polymor-
phisms is found in patients with 
inherited ataxias [19]. 
 
The expression of FGF14F145S reduces 
the α subunit Nav channels at the 
initial segment of axons, the currents 
of Nav channels, and the excitability 
of hippocampal neurons [20]. 
 
differential FGF13 expression pattern, where FGF13 is ex-
pressed in the brain during development but not in adult-
hood, whereas it is present in adult DRG neurons [23,24]. 
Such distinct expression patterns suggest differential roles 
of these FGFs in the nervous system throughout life.  
2  Role of intracellular FGFs in modulation of 
Nav channel activity 
With regard to the function of intracellular FGFs, accumu-
lated evidence shows that they are important for regulating 
the activity of Nav channels (Table 1). Intracellular FGFs 
are often colocalized with Nav channels at the initial seg-
ments of axons and nodes of Ranvier [10,31,32]. Therefore, 
these FGFs might modulate the intiation and the propaga-
tion of action potentials [11,33–35]. FGF12B was found to 
bind to Nav1.5 and Nav1.9 channels, but not to Nav1.7 or 
Nav1.8 [36,37]. The interaction of FGF12B with Nav1.5 
channel caused a hyperpolarizating shift in steady-state in-
activation [37]. FGF13B was found to associate with Nav1.6, 
which is present at the nodes of Ranvier along central and 
peripheral axons and unmyelinated afferent fibers in the pe-
ripheral nervous system. FGF13B increased the amplitude of 
Nav1.6 sodium currents in a transfected DRG-derived cell 
line ND7/23 [10]. Two alternatively spliced N-terminal 
FGF14 variants, FGF14-1a an FGF14-1b, differentially 
regulate currents produced by Nav1.2 and Nav1.6 channels 
[38]. Furthermore, intracellular FGF12 may be a component 
of tissue-specific protein kinase signaling modules, since 
FGF12 was found to interact with the MAP kinase (MAPK) 
scaffold protein Islet-Brain-2 (IB2) in the brain [22]. It re-
mains unclear whether these intracellular FGFs increase the 
open probability of channels upon membrane depolarization 
by binding to the C-terminus of Nav channels, by inserting 
more Nav channels into the plasma membrane from the cy-
tosolic pool, or by recruiting a kinase to the channel com-
plex and the subsequent phosphorylation of the channel. It 
would be interesting to study the correlation between the 
regulation of Nav channel activity and the signaling modules 
of intracellular FGFs in neurons.  
Analysis of the crystal structure of FGF13A reveals a 
conserved surface required for binding to the C-terminal 
domain of the pore-forming () subunits of Nav channels 
and for modulating the inactivation of Nav channels by par-
tially occluding the inner face of the pore [17]. The 
152-residue-long homologous region of intracellular FGFs 
is sufficient for channel binding, and the 18-residue-long, 
C-terminal extension of the homologous region plays an 
essential role in channel binding [17]. Alternative splicing 
at the N-terminus of intracellular FGFs does not contribute 
to their interaction with the C-terminal domain of Nav 
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channels. FGF13A induces a greater shift in the volt-
age-dependence of inactivation when compared with 
FGF13B [10,17,39]. This suggests that the alternatively 
spliced N-terminus of FGF13A is more effective in occlud-
ing the channel pore.  
Animal models of FGF-deficiency correlate with human 
diseases and give insight into the functions of intracellular 
FGFs. Studies show that Fgf12 knockout mice display mus-
cle weakness [5] (Table 1). FGF14-deficient mice develop 
ataxia, paroxysmal hyperkinetic movement disorder and 
cognitive impairment [13,32,40]. This may be attributed to 
the loss of FGF14, which impairs the intrinsic excitability of 
cerebellar Purkinje neurons [15] and the long-term potentia-
tion of synapses in the hippocampal CA1 region [16,31,40]. 
Likewise in humans, an autosomal dominant missense mu-
tation, FGF14F145S, results in progressive spinocerebellar 
ataxia and cognitive impairment [14,41]. This is because the 
stability of FGF14F145S is reduced, which leads to a loss of 
FGF14 function [18,41]. Furthermore, FGF14F145S may dis-
rupt the interaction of FGF14 with Nav1.2 channel and im-
pair neuronal excitability [42]. Frameshift mutation and 
polymorphisms of Fgf14 are also found in patients with 
inherited ataxias [20]. Therefore, FGF12 and FGF14 are 
important for regulating the neurotransmission of mo-
tor-functions. The functional roles of FGF13 expressed in 
adult hippocampal neurons and DRG neurons remain to be 
further investigated.  
3  FGF13 functions in neural development 
The extensive expression of FGF13 in the developing brain 
has prompted studies to investigate its functions. Early 
studies showed that FGF13 could induce tyrosine phos-
phorylation of mitogen-activated protein kinase (MAPK) 
and phospholipase C-gamma (PLC-γ) in hippocampal as-
trocytes [19]. Treatment of neuronal cultures from rat em-
bryonic cortex with FGF13 increased the number of neurons 
containing gamma-aminobutyric acid (GABA) and choline 
acetyltransferase enzymes [19]. FGF13 is also involved in 
Xenopus neural differentiation [43]. In addition, FGF13 
may be involved in limb development [44]. Pretreatment 
with intravenous FGF13 reduces infarct volume and ame-
liorates neurological deficits following focal cerebral is-
chemia in rats [45].  
During brain development, cortical neurons migrate from 
the site of their last mitotic division towards their final des-
tination and generate the proper neural circuits [46–48]. 
Proper regulation of microtubule dynamics during ax-
on/leading process formation is crucial for the transition of 
neurons from the multipolar stage to a bipolar morphology, 
and is a prerequisite for initiating radial migration [49–51]. 
Tubulins, a number of microtubule-regulating proteins that 
promote microtubule assembly and proteins that protect 
microtubules from depolymerization (such as microtubule-     
stabilizing proteins), are all involved in this regulatory pro-
cess [52]. Our recent study shows that FGF13B is a micro-
tubule-stabilizing protein that is enriched in the growth 
cones of cortical neurons [9] (Table 1). FGF13 was found to 
promote microtubule polymerization and stabilization, ena-
bling the polarization of developing cortical neurons. 
Knockdown of FGF13 expression impairs the polarization 
and migration of cortical neurons in developing brains of 
mice and rats [9] (Figure 2). Neuronal migration was de-
layed in both the neocortex and the CA1 region of hippo-
campus of Fgf13 knockout mice. Learning and memory 
were also impaired in these FGF13-deficient mice, although 
the positioning of neurons in the neocortex and hippocam-
pus of adult mutant mice was similar to that in control mice 
[9]. These data indicate an essential role of FGF13 in estab-
lishing neural circuits in the cerebral cortex and enabling 
cognitive functions. 
The core function of FGF13B in brain development is its 
direct interaction with tubulin via a tubulin-binding domain, 
FGF13BS104-Q111 [9]. Several members of the microtubule-       
stabilizing proetein family, such as microtubule-associated 
proteins and doublecortin (DCX), are essential for the early 
phase of neuronal migration [53–57]. Reduction in DCX 
also attenuates the transition of multipolar neurons to bipo-
lar ones in the developing cortex [54,58]. Interestingly, 
FGF13 is enriched in the axons of cortical neurons while its 
level in the dendrites is lower than DCX [9]. FGF13 and 
DCX may function independently during neural develop-
ment, because the inhibition of neuronal migration caused 
by loss of DCX could be rescued by overexpressing FGF13 
and vice versa. Therefore, it would be interesting to inves-
tigate the differential functions and correlations among 
FGF13, DCX and other microtubule-stabilizing proteins. 
4  FGF13 in X-linked mental retardation 
In humans, FGF11, FGF12, FGF13 and FGF14 genes are 
located on chromosome 17, 3, X and 13, respectively [7]. 
X-linked mental retardation (XLMR) is an inherited intel-
lectual disability with disordered neural development aris-
ing from many mutations along the X chromosome. Alt-
hough mutations resulting in XLMR have been reported in 
102 genes [59–61], only a few of them have been proven to 
directly cause intellectual disability via defined mechanisms 
that are supported by experimental approaches, such as in 
animal models. Interestingly, FGF13 is a candidate gene for 
the syndromal and non-specific forms of XLMR mapped to 
the q26 region of the X chromosome [5,12,6164]. Direct 
evidence for an important role of FGF13 gene in XLMR is 
the impairment of learning and memory in FGF13-deficient 
mice [9]. We found that FGF13 loss delayed neuronal mi-
gration in both the neocortex and the hippocampus, and 
impaired learning and memory [9], indicating that the 
FGF13 function is essential for the development of cortical  
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Figure 2  FGF13 is required for cerebral cortical development. A, To reduce the FGF13 expression, in utero electroporation with plasmids expressing 
short-hairpin-interfering RNA targeting FGF13 mRNA (FGF13 shRNA) or a negative control (shNC) was carried out at E16.5 in rats [9]. The brains were 
analyzed at different developmental stages. B, The FGF13 shRNA-expressing cortical neurons (green fluorescent protein-positive) examined at P14 showed 
multipolar instead of normal bipolar morphology. Scale bar, 100 m. C, FGF13 knockdown results in a neuronal migration defect in the somatosensory  
cortex of rats. The radial migration of cortical neurons was delayed in the deep cortical layers. Scale bar, 200 m. 
 
structures and cognitive functions. 
Duplication in Xq26 may contribute to XLMR [61,63,65]. 
Duplication may disrupt the coding or regulatory region of 
the gene located at its boundaries, or induce a dosage effect 
of proteins encoded by genes located within the duplicated 
region. In a Börjeson-Forssman-Lehmann syndrome-like 
patient, FGF13 may be interrupted by a duplication break-
point [63]. However, it has to be pointed out that the phe-
notypes induced by FGF13 mutations can be different be-
cause these various mutations can generate diverse isoforms 
[44,63]. Different FGF13 isoforms or mutants may have 
distinct expression patterns, subcellular distribution and 
functions in development. Therefore, the phenotypes of 
FGF13 gene mutations may be determined largely by the 
mutation sites and the mutated products.  
Although FGF13 is transiently expressed in the cerebral 
cortex only from E14 until P14 with a peak level at P7, 
FGF13-deficient mice exhibit marked defects in learning 
and memory. Therefore, the delayed neuronal migration and 
increased collateral branching of axons could disrupt the 
formation of the neural circuits and networks required for 
generating cognitive functions. At the moment, it remains 
unclear how synaptogenesis, action potential firing and 
synaptic transmission might be affected by loss of FGF13 
function in adulthood, but some effects are expected be-
cause FGF13 may regulate neuronal excitability through 
modulating Nav channels [10,17,32]. Therefore, FGF13-     
deficient mice may be a useful animal model for studying 
XLMR-related mechanisms.  
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